RE: Enhancing Capacity for Primary Care Research in Cancer Survivorship: National Cancer Institute Meeting Report

By sjmartinez • January 9, 2025

McClellan SP, Rivera-Avila DA, Cardenas E, Pérez-Zepeda MU, Dykens JA, Weine SM, Fitzgibbon M, Ganz P, García-Peña C. RE: Enhancing Capacity for Primary Care Research in Cancer Survivorship: National Cancer Institute Meeting Report. J Natl Cancer Inst. 2025 Jan 8:djae346. doi: 10.1093/jnci/djae346. Epub ahead of print. PMID: 39775888.

Tags: Hematology/Oncology, Publications

Five-Year Follow-Up Analysis of ZUMA-5: Axicabtagene Ciloleucel in Relapsed/Refractory Indolent Non-Hodgkin Lymphoma

Neelapu SS, Chavez JC, Sehgal AR, Epperla N, Ulrickson ML, Bachy E, Munshi PN, Casulo C, Maloney DG, de Vos S, Reshef R, Leslie LA,[...]

A Decade After Approval of the First CDK4/6 Inhibitor: A Look Back at Palbociclib’s Journey from Discovery to Approval and What’s Next in CDK Inhibition in Breast Cancer

Finn RS, Rugo HS, Cortes J, Loibl S, Foley G, Gauthier E, Wang Y, Kim S, Anders L, Slamon DJ. A Decade After Approval of[...]

Corrigendum to “Associations of Tissue Tumor Mutational Burden and Mutational Status With Clinical Outcomes With Pembrolizumab Plus Chemotherapy Versus Chemotherapy For Metastatic NSCLC [JTO Clinical and Research Reports Vol. 4 No. 1: 100431]

Garassino MC, Gadgeel S, Novello S, Halmos B, Felip E, Speranza G, Hui R, Garon EB, Horinouchi H, Sugawara S, Rodriguez-Abreu D, Reck M, Cristescu[...]